Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
The NIH Office of AIDS Research (OAR) leads the effort across NIH to establish HIV research priorities and develop the NIH Strategic Plan for HIV and HIV-Related Research.News Article updated on 02/15/2024
-
Toolkit Features State Strategies to Improve the Health of People with HIV
HHS has supported development of a toolkit on state Medicaid and health department coordination to improve HIV care delivery.
Blog updated 12/28/2022
-
Centers for Disease Control and Prevention (CDC)
Federal agency within HHS responsible for promotion of health and well-being of Americans.
Resource updated 07/17/2024
-
Recap: 17th Ryan White HIV/AIDS Program Clinical Care Conference
Highlights from the 2017 Ryan White Clinical Conference by Dr. Laura Cheever.
Blog updated 01/13/2023
-
AETC National Coordinating Resource Center (NCRC)
HIV clinical training resources for HRSA's AIDS Education and Training Centers Program.
Resource updated 07/18/2024
-
Engaging Historically Black Colleges and Universities in HIV Prevention
Research shows that African American students live with HIV more commonly than their primarily Caucasian counterparts. Historically black colleges and universities (HBCUs) educate millions of learners, positioning these entities to enact greater strategies to counter HIV acquisition and spread. This workshop describes an innovative partnership to address such factors at HBCUs.
Resource (Conference Presentation) updated 07/17/2024
-
National HIV Curriculum
Online clinician training platform with evidence-based core competency training on HIV prevention, screening, diagnosis, care, and key populations.
Resource updated 07/18/2024
-
National HIV PrEP Curriculum
Online learning portal for clinicians on pre-exposure prophylaxis (PrEP) for prevention of HIV.Resource updated 07/18/2024
-
340B Drug Pricing Program
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 07/18/2024
-
Doxy PEP Guidelines Issued by CDC
CDC has issued the first-ever guidelines recommending use of doxy PEP (doxycycline postexposure prophylaxis) for the prevention of STIs among select populations.News Article updated on 06/06/2024 -
OI Guidelines Update on Anal Cancer Screening
A panel of experts in HIV care has released new recommendations to prevent anal cancer for people with HIV, the first U.S. federal guidelines on the topic.News Article updated on 07/11/2024 -
Mpox Treatment Study Underway: How to Take Part
Insights on how to take part in the clinical trial are outlined in HIV.gov's Help Scientists Find a Safe and Effective Mpox Treatment.News Article updated on 05/17/2024 -
Mpox Emergency is Over
The mpox emergency declaration ended at the end of January 2023.News Article updated on 02/02/2023 -
Keeping Up-to-Date on Mpox
The nation quickly got the Mpox outbreak of 2022-2023 under control. Some cities did great work in getting people at risk vaccinated. Some, not so good. Diligence is in order.News Article updated on 07/16/2024 -
Funding Opportunity: A System-Level Syndemic Approach to Improve HIV Care and Treatment for People from Racial and Ethnic Minority Groups – DEMONSTRATION SYSTEMS (HRSA-24-107)
This HRSA HIV/AIDS Bureau pre-application webinar is for the funding opportunity, A System-Level Syndemic Approach to Improve HIV Care and Treatment for People from Racial and Ethnic Minority Groups – Demonstration Systems (HRSA-24-107).Resource updated 07/19/2024
-
Funding Opportunity: A System-Level Syndemic Approach to Improve HIV Care and Treatment for People from Racial and Ethnic Minority Groups – EVALUATION AND TA PROVIDER (HRSA-24-108)
This HRSA HIV/AIDS Bureau pre-application webinar is for the funding opportunity, A System-Level Syndemic Approach to Improve HIV Care and Treatment for People from Racial and Ethnic Minority Groups – EVALUATION AND TA PROVIDER (HRSA-24-108).Resource updated 07/19/2024
-
Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024 -
Syphilis Cases Continue to Climb
Syphilis cases continue to climb in the U.S. In April 2023, CDC reported a 32% increase in cases from 2020 to 2021 (133,954 to 176.713 cases). In 2022, cases had jumped yet again, to 203,500.News Article updated on 03/04/2024 -
Rapid ART Program Initiative for New Diagnoses
Rapid ART Program Initiative for New Diagnoses (RAPID) was designed to connect people with a new HIV diagnosis to ART within five days of diagnosis and within one day of their initial care visit. Linkage navigators counseled people on HIV care, identified an available clinician capable of immediately prescribing ART, scheduled the clinical appointment, and connected people to additional support services. RAPID led to a reduction in median time between initial diagnosis and both ART initiation and viral suppression.Resource from the RWHAP Best Practices Compilation updated on 07/04/2024
-
Journey Mapping (Encore Presentation)
Attendees will gain insights into the process of constructing patient journey maps collaboratively within their communities.Event updated 07/17/2024